Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies

被引:63
|
作者
Xuan, Li [1 ]
Huang, Fen [1 ]
Fan, Zhiping [1 ]
Zhou, Hongsheng [1 ]
Zhang, Xian [1 ]
Yu, Guopan [1 ]
Zhang, Yu [1 ]
Liu, Can [1 ]
Sun, Jing [1 ]
Liu, Qifa [1 ]
机构
[1] So Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou 510515, Guangdong, Peoples R China
来源
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
Epstein-Barr virus; Cytomegalovirus; Conditioning; Hematological malignancies; Allogeneic hematopoietic stem cell transplantation; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; VERSUS-HOST-DISEASE; HIGH-RISK PATIENTS; IMMUNE RECONSTITUTION; REGIMENS; CHEMOTHERAPY; STRATEGIES;
D O I
10.1186/1756-8722-5-46
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intensified conditioning regimens (increasing the intensity of standard myeloablative conditioning) for hematological malignancies in allogeneic hematopoietic stem cell transplantation (allo-HSCT) could reduce the relapse rate of the underlying disease, but it might simultaneously increase the transplant-related mortality including the mortality of infections. To explore whether intensified conditioning affected Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections, 185 patients undergoing allo-HSCT were enrolled. Methods: A total of 104 cases received standard and 81 intensified conditioning. Cyclosporine A (CsA) withdrawal and/or donor lymphocyte infusion (DLI) were conducted in high-risk patients. The EBV-DNA and CMV-DNA levels of blood were monitored regularly by quantitative real-time polymerase chain reaction (RQ-PCR) and immune reconstitution of recipients were analyzed by flow cytometry. Results: The 3-year cumulative incidence of EBV viremia, EBV-associated diseases and mortality of EBV-associated diseases were 25.3%+/- 4.6%, 10.5%+/- 3.4% and 0.0%+/- 0.0% in the standard group, compared with 45.6%+/- 6.5%, 26.0%+/- 5.3% and 7.3%+/- 3.1% in the intensified group (P=0.002, P=0.002, P=0.008). The 3-year cumulative incidence of CMV viremia and CMV-associated diseases, mortality of CMV-associated diseases and incidence of bacterial and fungal infections were similar between the two groups (P=0.855, P=0.581, P=0.933, P=0.142, P=0.182, respectively). Multivariate analysis showed that intensified conditioning was one of the risk factors for EBV viremia and EBV-associated diseases (P=0.037, P=0.037), but it had no effects on CMV infections. The percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio at 3 months post-transplantation were lower in the intensified group (P=0.032, P=0.022). The 3-year OS and DFS in the standard group were 62.2%+/- 5.8% and 60.6%+/- 5.6%, compared with 51.6%+/- 6.2% and 51.1% +/- 5.9% in the intensified group (P=0.029, P=0.063). Conclusions: Intensified conditioning represents a promising approach for high-risk hematological malignancies, although it affects early immune reconstitution of recipients and increases the incidence and mortality of EBV infections.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
    Li Xuan
    Fen Huang
    Zhiping Fan
    Hongsheng Zhou
    Xian Zhang
    Guopan Yu
    Yu Zhang
    Can Liu
    Jing Sun
    Qifa Liu
    Journal of Hematology & Oncology, 5
  • [2] EPSTEIN-BARR VIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE ROLE OF CYTOMEGALOVIRUS
    Liu, Q.
    Lin, R.
    Liu, C.
    Wu, M.
    Xuan, L.
    Jiang, X.
    Fan, Z.
    Zhang, Y.
    Huang, F.
    Zhou, H.
    Dai, M.
    Sun, J.
    HAEMATOLOGICA, 2014, 99 : 421 - 422
  • [3] Epstein-Barr Virus Infection In Recipient Of Allogeneic Hematopoietic Stem Cell Transplantation: The Role Of Cytomegalovirus
    Liu, Qifa
    Lin, Ren
    Liu, Can
    Wu, Meiqing
    Xuan, Li
    Jiang, Xinmiao
    Fan, Zhiping
    Zhang, Yu
    Huang, Fen
    Zhou, Hongsheng
    Dai, Min
    Sun, Jing
    BLOOD, 2013, 122 (21)
  • [4] Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients
    Lazzarotto, Tiziana
    Chiereghin, Angela
    Piralla, Antonio
    Piccirilli, Giulia
    Girello, Alessia
    Campanini, Giulia
    Gabrielli, Liliana
    Costa, Cristina
    Prete, Arcangelo
    Bonifazi, Francesca
    Busca, Alessandro
    Cairoli, Roberto
    Colombo, Anna Amelia
    Zecca, Marco
    Sidoti, Francesca
    Bianco, Gabriele
    Paba, Pierpaolo
    Perno, Carlo Federico
    Cavallo, Rossana
    Baldanti, Fausto
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1699 - 1706
  • [5] Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
    Z Peric
    X Cahu
    P Chevallier
    E Brissot
    F Malard
    T Guillaume
    J Delaunay
    S Ayari
    V Dubruille
    S Le Gouill
    B Mahe
    T Gastinne
    N Blin
    B Saulquin
    J-L Harousseau
    P Moreau
    N Milpied
    M Coste-Burel
    B-M Imbert-Marcille
    M Mohty
    Leukemia, 2011, 25 : 932 - 938
  • [6] Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
    Peric, Z.
    Cahu, X.
    Chevallier, P.
    Brissot, E.
    Malard, F.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Harousseau, J-L
    Moreau, P.
    Milpied, N.
    Coste-Burel, M.
    Imbert-Marcille, B-M
    Mohty, M.
    LEUKEMIA, 2011, 25 (06) : 932 - 938
  • [7] Monitoring of cytomegalovirus, Epstein-Barr virus and adenovirus infections in hematopoietic stem cell transplant recipients
    Seflek, Buket
    Gumus, Hatice Hale
    Cimentepe, Mehmet
    Kupeli, Serhan
    Yarkin, Fugen
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 432 - 440
  • [8] Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation
    Zallio, Francesco
    Primon, Valeria
    Tamiazzo, Stefania
    Pini, Massimo
    Baraldi, Anna
    Corsetti, Maria T.
    Gotta, Franca
    Bertassello, Claudia
    Salvi, Flavia
    Rocchetti, Andrea
    Levis, Alessandro
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : E491 - E497
  • [9] Investigation of Cytomegalovirus, Epstein-Barr Virus and Adenovirus Infections After Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
    Kaya, Nazli Nida
    Kupeli, Serhan
    Ozturk, Gokhan
    Bayram, Ibrahim
    Ozdogru Sagdic, Deniz
    Sezgin, Gulay
    Koksal, Fatih
    Yarkin, Fugen
    FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2018, 23 (01): : 15 - 24
  • [10] Use of Rituximab in Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation
    Song, Li
    Wang, Pei-Jun
    Zhang, Mei-Ping
    Ji, Chun-Xiao
    Wang, Ling
    Li, Ying
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (05): : 2439 - 2443